446 related articles for article (PubMed ID: 16370407)
1. Treatment of irritable bowel syndrome.
Hadley SK; Gaarder SM
Am Fam Physician; 2005 Dec; 72(12):2501-6. PubMed ID: 16370407
[TBL] [Abstract][Full Text] [Related]
2. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
Prescrire Int; 2009 Apr; 18(100):75-9. PubMed ID: 19585728
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
Rahimi R; Nikfar S; Abdollahi M
Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis: The treatment of irritable bowel syndrome.
Lesbros-Pantoflickova D; Michetti P; Fried M; Beglinger C; Blum AL
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1253-69. PubMed ID: 15606387
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and therapeutic strategies in the irritable bowel syndrome.
Cremonini F; Talley NJ
Minerva Med; 2004 Oct; 95(5):427-41. PubMed ID: 15467518
[TBL] [Abstract][Full Text] [Related]
6. The role of loperamide in gastrointestinal disorders.
Hanauer SB
Rev Gastroenterol Disord; 2008; 8(1):15-20. PubMed ID: 18477966
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of IBS in adults.
Wilkins T; Pepitone C; Alex B; Schade RR
Am Fam Physician; 2012 Sep; 86(5):419-26. PubMed ID: 22963061
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of current drug therapies in irritable bowel syndrome: what works and does not work.
Schoenfeld P
Gastroenterol Clin North Am; 2005 Jun; 34(2):319-35, viii. PubMed ID: 15862938
[TBL] [Abstract][Full Text] [Related]
9. Irritable bowel syndrome.
Mertz HR
N Engl J Med; 2003 Nov; 349(22):2136-46. PubMed ID: 14645642
[No Abstract] [Full Text] [Related]
10. Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome.
Leventer SM; Raudibaugh K; Frissora CL; Kassem N; Keogh JC; Phillips J; Mangel AW
Aliment Pharmacol Ther; 2008 Jan; 27(2):197-206. PubMed ID: 17973974
[TBL] [Abstract][Full Text] [Related]
11. Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial.
Cappello G; Spezzaferro M; Grossi L; Manzoli L; Marzio L
Dig Liver Dis; 2007 Jun; 39(6):530-6. PubMed ID: 17420159
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled study to assess efficacy and safety of 0.5 mg and 1 mg alosetron in women with severe diarrhea-predominant IBS.
Krause R; Ameen V; Gordon SH; West M; Heath AT; Perschy T; Carter EG
Am J Gastroenterol; 2007 Aug; 102(8):1709-19. PubMed ID: 17509028
[TBL] [Abstract][Full Text] [Related]
13. The brain-gut axis in irritable bowel syndrome--clinical aspects.
Mach T
Med Sci Monit; 2004 Jun; 10(6):RA125-31. PubMed ID: 15173682
[TBL] [Abstract][Full Text] [Related]
14. Tegaserod for constipation-predominant irritable bowel syndrome.
Kale-Pradhan PB; Wilhelm SM
Pharmacotherapy; 2007 Feb; 27(2):267-77. PubMed ID: 17253916
[TBL] [Abstract][Full Text] [Related]
15. Options for patients with irritable bowel syndrome: contrasting traditional and novel serotonergic therapies.
Johanson JF
Neurogastroenterol Motil; 2004 Dec; 16(6):701-11. PubMed ID: 15601419
[TBL] [Abstract][Full Text] [Related]
16. Review article: clinical evidence to support current therapies of irritable bowel syndrome.
Camilleri M
Aliment Pharmacol Ther; 1999 May; 13 Suppl 2():48-53. PubMed ID: 10429740
[TBL] [Abstract][Full Text] [Related]
17. Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome.
Chey WD; Chey WY; Heath AT; Dukes GE; Carter EG; Northcutt A; Ameen VZ
Am J Gastroenterol; 2004 Nov; 99(11):2195-203. PubMed ID: 15555002
[TBL] [Abstract][Full Text] [Related]
18. The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study.
Bardhan KD; Forbes A; Marsden CL; Mason T; Short G
Aliment Pharmacol Ther; 2004 Jul; 20(2):213-22. PubMed ID: 15233702
[TBL] [Abstract][Full Text] [Related]
19. Treatment of irritable bowel syndrome.
Trinkley KE; Nahata MC
J Clin Pharm Ther; 2011 Jun; 36(3):275-82. PubMed ID: 21545610
[TBL] [Abstract][Full Text] [Related]
20. A review of irritable bowel syndrome and an update on therapeutic approaches.
Bassett JT; Cash BD
Expert Opin Pharmacother; 2008 May; 9(7):1129-43. PubMed ID: 18422471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
